These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1159 related articles for article (PubMed ID: 22508111)

  • 1. Transapical transcatheter aortic valve implantation using the JenaValve™ system: acute and 30-day results of the multicentre CE-mark study.
    Treede H; Mohr FW; Baldus S; Rastan A; Ensminger S; Arnold M; Kempfert J; Figulla HR
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):e131-8. PubMed ID: 22508111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transapical transcatheter aortic valve implantation using a new second-generation TAVI system - J-Valve™ for high-risk patients with aortic valve diseases: Initial results with 90-day follow-up.
    Zhu D; Chen Y; Guo Y; Hu J; Zhang J; Wei X; Tang H; Shi Y
    Int J Cardiol; 2015 Nov; 199():155-62. PubMed ID: 26197402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new self-expanding transcatheter aortic valve for transapical implantation - first in man implantation of the JenaValve™.
    Kempfert J; Rastan AJ; Mohr FW; Walther T
    Eur J Cardiothorac Surg; 2011 Sep; 40(3):761-3. PubMed ID: 21334914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trans-apical aortic valve implantation using a new self-expandable bioprosthesis: initial outcomes.
    Kempfert J; Rastan AJ; Beyersdorf F; Schönburg M; Schuler G; Sorg S; Mohr FW; Walther T
    Eur J Cardiothorac Surg; 2011 Nov; 40(5):1114-9. PubMed ID: 21924620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcatheter aortic valve implantation of a second-generation valve for pure aortic regurgitation: procedural outcome, haemodynamic data and follow-up.
    Schlingloff F; Schäfer U; Frerker C; Schmoeckel M; Bader R
    Interact Cardiovasc Thorac Surg; 2014 Sep; 19(3):388-93. PubMed ID: 24893871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial German experience with transapical implantation of a second-generation transcatheter heart valve for the treatment of aortic regurgitation.
    Seiffert M; Bader R; Kappert U; Rastan A; Krapf S; Bleiziffer S; Hofmann S; Arnold M; Kallenbach K; Conradi L; Schlingloff F; Wilbring M; Schäfer U; Diemert P; Treede H
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1168-74. PubMed ID: 25129672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcarotid aortic valve-in-valve implantation for degenerated stentless aortic root conduits with severe regurgitation: a case series.
    Huber C; Praz F; O'Sullivan CJ; Langhammer B; Gloekler S; Stortecky S; von Allmen RS; Meier B; Carrel T; Englberger L; Windecker S; Wenaweser P
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):694-700. PubMed ID: 25776924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transapical transcatheter aortic valve implantation without prior balloon aortic valvuloplasty: feasible and safe.
    Conradi L; Seiffert M; Schirmer J; Koschyk D; Blankenberg S; Reichenspurner H; Diemert P; Treede H
    Eur J Cardiothorac Surg; 2014 Jul; 46(1):61-6. PubMed ID: 24335266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transapical aortic valve implantation in patients with previous cardiac surgery.
    Papadopoulos N; Ilioska P; Fichtlscherer S; Lehmann R; Beiras Fernandez A; Moritz A; Doss M; Zierer A
    Ann Thorac Surg; 2014 Jan; 97(1):37-42. PubMed ID: 24075497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transcatheter aortic valve implantation (TAVI)TAVI): A new therapeutic option for patients with severe symptomatic aortic stenosis who are not suitable or at high risk for surgical valve replacement].
    Zahn R; Schiele R; Kilkowski C; Klein B; Schwarz AK; Zeymer U; Lehmann A; Cornelius B; Horack M; Saggau W; Werling C
    Dtsch Med Wochenschr; 2010 Aug; 135(33):1589-95. PubMed ID: 20717862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfemoral valve-in-valve implantation for degenerated bioprosthetic aortic valves using the new balloon-expandable Edwards Sapien 3 valve.
    Gonska B; Seeger J; Rodewald C; Scharnbeck D; Rottbauer W; Wöhrle J
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):636-643. PubMed ID: 27142354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Worldwide experience with the 29-mm Edwards SAPIEN XT™ transcatheter heart valve in patients with large aortic annulus.
    Wendler O; Thielmann M; Schroefel H; Rastan A; Treede H; Wahlers T; Eichinger W; Walther T
    Eur J Cardiothorac Surg; 2013 Feb; 43(2):371-7. PubMed ID: 22522982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JenaValve.
    Treede H; Rastan A; Ferrari M; Ensminger S; Figulla HR; Mohr FW
    EuroIntervention; 2012 Sep; 8 Suppl Q():Q88-93. PubMed ID: 22995119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexpected complications of transapical aortic valve implantation.
    Al-Attar N; Ghodbane W; Himbert D; Rau C; Raffoul R; Messika-Zeitoun D; Brochet E; Vahanian A; Nataf P
    Ann Thorac Surg; 2009 Jul; 88(1):90-4. PubMed ID: 19559200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermediate follow-up results from the multicenter engager European pivotal trial.
    Holzhey D; Linke A; Treede H; Baldus S; Bleiziffer S; Wagner A; Börgermann J; Scholtz W; Vanoverschelde JL; Falk V
    Ann Thorac Surg; 2013 Dec; 96(6):2095-100. PubMed ID: 24021766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PREVAIL TRANSAPICAL: multicentre trial of transcatheter aortic valve implantation using the newly designed bioprosthesis (SAPIEN-XT) and delivery system (ASCENDRA-II).
    Walther T; Thielmann M; Kempfert J; Schroefel H; Wimmer-Greinecker G; Treede H; Wahlers T; Wendler O
    Eur J Cardiothorac Surg; 2012 Aug; 42(2):278-83; discussion 283. PubMed ID: 22293620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter aortic valve implantation with a self-expanding nitinol bioprosthesis: prediction of the need for permanent pacemaker using simple baseline and procedural characteristics.
    Saia F; Lemos PA; Bordoni B; Cervi E; Boriani G; Ciuca C; Taglieri N; Mariani J; Kalil Filho R; Marzocchi A
    Catheter Cardiovasc Interv; 2012 Apr; 79(5):712-9. PubMed ID: 22109957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valve-in-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves.
    Eggebrecht H; Schäfer U; Treede H; Boekstegers P; Babin-Ebell J; Ferrari M; Möllmann H; Baumgartner H; Carrel T; Kahlert P; Lange P; Walther T; Erbel R; Mehta RH; Thielmann M
    JACC Cardiovasc Interv; 2011 Nov; 4(11):1218-27. PubMed ID: 22115663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transapical aortic valve implantation using a new self-expandable bioprosthesis (ACURATE TA™): 6-month outcomes.
    Kempfert J; Treede H; Rastan AJ; Schönburg M; Thielmann M; Sorg S; Mohr FW; Walther T
    Eur J Cardiothorac Surg; 2013 Jan; 43(1):52-6; discussion 57. PubMed ID: 22491663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transapical aortic valve implantation in Rouen: four years' experience with the Edwards transcatheter prosthesis.
    Litzler PY; Borz B; Smail H; Baste JM; Nafeh-Bizet C; Gay A; Tron C; Godin M; Caudron J; Hauville C; Dacher JN; Cribier A; Eltchaninoff H; Bessou JP
    Arch Cardiovasc Dis; 2012 Mar; 105(3):141-5. PubMed ID: 22520796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.